Protalix BioTherapeutics (PLX) Reports Encouraging Data from Taliglucerase Alfa in Type 1 Gaucher Disease
Tweet Send to a Friend
Protalix BioTherapeutics, Inc. (AMEX: PLX) announced today that new clinical data on taliglucerase alfa was presented at the 10th Annual ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
